Sumatriptan succinate and prochlorperazine maleate are a clinically proven combination for treating migraine and associated nausea and vomiting. Classical oral dosage forms are not frequently workable in migraine because of the associated nausea/vomiting, and no effective fixed dose combination is available. Thus, the aim of the study was to optimize a combined sumatriptan-prochlorperazine orodispersible film for rapid release of drugs. Orodispersible films were prepared by solvent casting method using varied amounts of polyvinyl alcohol and glycerol as film former and plasticizer, respectively, along with fixed levels of other ingredients employing central composite design. The optimum film (VF) demonstrated disintegration and total dispersion times as 21 s and 2.3 min, respectively. Tensile strength and Young's modulus were 8.86 ± 0.37 MPa and 24.15 ± 0.07 MPa, respectively. The in vitro T80% of both drugs from the ODF was achieved within 4 min. The film was palatable and disintegrated in 2 min in buccal cavity of human volunteers. Permeation study through goat mucosa demonstrated 100% permeation of both drugs within 15 min. X-Ray diffraction and differential scanning calorimetry supported drugs being amorphous and Fourier transform infrared demonstrated drug-excipient compatibility in optimized film. A judicious combination of sumatriptan succinate and prochlorperazine maleate could be prepared in orodispersible films for the possible relief of migraine.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1208/s12249-022-02307-8 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A review of precision medicine in developing pharmaceutical products: Perspectives and opportunities.
Int J Pharm
December 2024
Pharmacogenomics (PGx) Laboratory, University of Puerto Rico, Medical Sciences Campus, San Juan, PR, 00936, United States; Department of Pharmaceutical Sciences, School of Pharmacy, University of Puerto Rico - Medical Sciences Campus, San Juan, PR 00936, United States. Electronic address:
Over the next decade, Precision Medicine (PM) is poised to become the standard of care in pharmaceutical therapy, necessitating a fundamental transformation in the design and development of innovative custom-made drug products. To date, a comprehensive review linking PM with practical personalized drug formulations is missing. This review attempts to provide an overview of state-of-the-art formulation approaches capable of translating PM evaluation and resulting recommendations (clinical research) into tailored drug products (non-clinical research) for real-world patients.
View Article and Find Full Text PDFHydroxypropyl methylcellulose stabilized clove oil nanoemulsified orodispersible films: Study of physicochemical properties, release profile, mucosal permeation, and anti-bacterial activity.
Int J Biol Macromol
December 2024
Plantation Products, Spices & Flavour Technology Department, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, Uttar Pradesh 201002, India. Electronic address:
Hydroxypropyl methylcellulose (HPMC)-based nanoemulsions for quick dissolving orodispersible (OD) films were prepared to encapsulate clove oil (CO) to harness its anti-bacterial properties. The influence of additives maltodextrin, pectin, and glycerol on the OD films was studied. The nanoemulsion particle size varied from 135 nm to 195 nm.
View Article and Find Full Text PDFHomogeneity and mechanical properties of orodispersible films loaded with pellets.
Eur J Pharm Biopharm
December 2024
Medical University of Gdansk, Department of Pharmaceutical Technology, Hallera Str. 107, 80-416 Gdansk, Poland. Electronic address:
Orodispersiblefilms(ODFs) have served as an emerging platform for the delivery of drugs in a convenient way. The production of ODFs with incorporated pellets may still be a challenging process due to problems to obtain proper homogeneity and deteriorating mechanical properties of the films with incorporated relatively big particles in high concentration. The goal of this work was to evaluate the possibility to achieve fast disintegrating ODFs with homogenously incorporated spherical granules without loss of required mechanical properties.
View Article and Find Full Text PDFOptimization and characterization of a dose-controllable orodispersible dexamethasone film for personalized medicine.
J Pharm Sci
December 2024
Meiji Pharmaceutical University, 2-522-1, Noshio, Kiyose, Tokyo 204-8588, Japan.
Decadron® tablets are commercially available in 0.5 and 4 mg formulations, often requiring the use of multiple tablets or fractional doses when the required dosage is unavailable. This practice can lead to inaccuracies and handling difficulties associated with tablet splitting and crushing tablets into powder.
View Article and Find Full Text PDFPreparation and In Vitro Evaluation of Montelukast Sodium-Loaded 3D Printed Orodispersible Films for the Treatment of Asthma.
AAPS PharmSciTech
September 2024
University of Health Sciences, Faculty of Pharmacy, Department of Pharmaceutical Technology, Üsküdar, 34668, Istanbul, Turkey.
Article Synopsis
- - The research focuses on creating orodispersible films (ODFs) for delivering montelukast sodium, a medication for asthma and allergic rhinitis, using 3D printing and various excipients like propylene glycol and hydroxypropyl methylcellulose.
- - ODFs achieved quick disintegration (around 40 seconds) and rapid drug release (over 98% within 2 minutes), indicating their effectiveness in delivering the drug.
- - Formulations Fm1-4 and Fm2-4 showed the best drug content and durability, with no toxic effects observed, making these ODFs a promising option for treating asthma and allergic rhinitis.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!